EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantitative assessment of china’s policies on the online sale of prescription drugs

Yuhang Zhang, Yuanyuan Zhang, Chenjian Zhao, Xingjuan Xu, Guoqing Wang, Xuefeng Xie iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0358484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Yuhang Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui Medical University, Hefei Anhui, China. Hauptthemen laut MEDLINE: Prescription Drugs, Commerce. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2021 Collaborative Innovation Project for Major Scientific Research Projects in Anhui Provincial Universities, Regulatory Science Research on Online Sales of Pharmaceuticals and Medical Devices, the Funding for the Disciplines at the School of Pharmacy, Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Against the dual backdrop of the rapid advancement of big data-driven healthcare and the COVID-19 pandemic, China has gradually relaxed restrictions on the online sale of prescription drugs. However, the regulatory framework governing this sector remains in its early stage of development, and existing policy gaps pose substantial risks to public medication safety, highlighting the urgent need for further policy refinement. This study quantitatively analyzed China’s policies on the online sale of prescription drugs, thus providing valuable insights for the development and improvement of future policies. Using ROST CM6.0, text mining was conducted on 18 policies governing the online sale of prescription drugs issued between 1999 and 2023. A Policy Model Consistency (PMC) model was established based on 10 primary variables and 35 secondary variables. The analysis yielded an average PMC index of 6.28, resulting in an overall policy rating of “good.” Among the 18 policies, 6 were classified as excellent and 12 as good, with no policies rated as perfect or unqualified. Amid the continuous exploration of policy and reforms, China’s policy system for the online sale of prescription drugs has been gradually improved. Current policies place strong emphasis on the efficiency of smart approaches and the steady development of an intelligent regulatory system. However, considerable opportunities for optimization remains in key areas, including the whole-process regulatory system for the online sale of prescription drugs, the collaborative participation of medical institutions, and the standardized governance of third-party platforms. Future policies should focus on the regulations governing the online sale of prescription drugs by clarifying the boundaries, rights and responsibilities of each subject while refining and standardizing their code of conduct. Multidepartment collaboration should also be strengthened by encouraging industry associations in the development of an intelligent regulatory team, thereby promoting the establishment of a three-dimensional digital regulatory pattern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prescription DrugsCommerceChinaHumansCOVID-19Internet

Substanzen

Prescription Drugs

Autor:innen und Institutionen

  • School of Pharmacy, Anhui Medical University, Hefei Anhui, China.
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei Anhui, China.
  • Anhui Provincial Drug Regulatory Scientific Research Center, Anhui Medical University, Hefei Anhui, China.
  • Key Laboratory of Public Health Social Governance, Philosophy and Social Sciences of Anhui Province, Anhui Medical University, Hefei Anhui, China.

ORCID-Profile: Xuefeng Xie

Förderung

  • 2021 Collaborative Innovation Project for Major Scientific Research Projects in Anhui Provincial Universities
  • Regulatory Science Research on Online Sales of Pharmaceuticals and Medical Devices
  • the Funding for the Disciplines at the School of Pharmacy, Anhui Medical University

Zitieren

APA

Zhang, Y., Zhang, Y., Zhao, C., Xu, X., Wang, G., & Xie, X. (2026). Quantitative assessment of china’s policies on the online sale of prescription drugs. PLOS One. https://doi.org/10.1371/journal.pone.0358484

Vancouver

Zhang Y, Zhang Y, Zhao C, Xu X, Wang G, Xie X. Quantitative assessment of china’s policies on the online sale of prescription drugs. PLOS One. 2026. doi:10.1371/journal.pone.0358484

BibTeX
@article{Zhang2026,
  author = {Zhang, Yuhang and Zhang, Yuanyuan and Zhao, Chenjian and Xu, Xingjuan and Wang, Guoqing and Xie, Xuefeng},
  title = {Quantitative assessment of china’s policies on the online sale of prescription drugs},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0358484}
}
Kostenlos starten →